Lymphoma (includes NHL, HL, CNS Lymphoma)
Featured Articles
(BioPharma Dive) Dec 5, 2018 - Like many a medical meeting, ASH showcased data that — while promising — also offers as many questions as answers. With another American Society of Hematology meeting in the books, the industry can take a minute to appreciate the notable advances seen in San Diego earlier this week. A new...
Read Article
(ASH) Dec 4, 2018 - Three studies being presented today during the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego offer more targeted solutions for managing CLL and multiple myeloma. “The most important take home point is that all three of these late-breaking studies demonstrate how targeted...
Read Article
Latest Articles
December 10, 2018
December 06, 2018
December 05, 2018
December 04, 2018
December 04, 2018
December 04, 2018
December 04, 2018
December 04, 2018
View More
News Commentary
Editor Image
16 Nov, 2018 | by
It seems too early to approve this drug.
View Comment
Editor Image
09 Apr, 2018 | by Winston Wong, PharmD
CMS has set the reimbursement for their near normal outpatient rate, thus CMS...
View Comment
View More
OBR Green
There are no Lymphoma (includes NHL, HL, CNS Lymphoma) OBR Green articles.
OBR Blog
By Lynne Lederman, PhD As the 2018 American Society of Hematology (ASH) Annual Meeting continues, we focus on two... Read more
December 03, 2018